首页 > 市场调查报告书 > 材料

市场调查报告书

商品编码

1629872

全球药品泡罩包装市场 - 2024-2032

Global Pharma Blisters Packaging Market - 2024-2032

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球药品泡罩包装市场规模达到58.3亿美元，预计2032年将达到87.2亿美元，2024-2032年预测期间复合年增长率为4.7%。

药品泡罩包装市场包括使用预成型塑胶包装，旨在安全地容纳单一剂量的药物，例如片剂、胶囊和锭剂。此包装解决方案透过提供有效的空气、湿气和污染屏障保护，对于延长药品的保质期至关重要。泡罩包装通常由热成型塑胶或铝形成的空腔组成，通常用纸板或箔等背衬材料密封。

市场动态：

驱动程式和限制

包装技术的创新

包装技术的创新预计将透过提高安全性、提高患者依从性和促进永续性来显着推动药品泡罩包装市场。最近的进展集中在整合智慧技术，例如感测器和追踪设备，它们可以监控药物使用和有效期限。

另一项重大创新是永续包装解决方案的发展。干模纤维 (DMF) 和纸基吸塑包装等环保替代品正成为传统塑胶包装的可行替代品。这些材料既可回收又可生物降解，解决了环境问题，同时仍为药品提供必要的保护品质。例如，2024 年 7 月，Aluflexpack 宣布开发新产品 4-Infinity Form。这款泡罩包装专为製药行业设计，完全由漆铝製成，为传统的多材料包装提供可持续且可回收的替代品。 4-Infinity Form 解决方案解决了药品包装产业对环境影响日益增长的担忧。

设计的进步也使泡罩包装更加人性化，特别是对于老年人等弱势群体。儿童防护机制和老年人友善设计等功能可确保药物保持安全且易于使用。例如，2024 年 11 月，Schreiner MediPharm 推出了一款新型儿童安全智慧吸塑钱包。本产品为临床试验提供安全、智慧的包装解决方案。 Schreiner MediPharm 提供各种用于临床试验的智慧泡罩包装。

可自订剂量追踪工具的引入使患者能够轻鬆监控他们的用药时间表，从而提高依从性并改善健康结果。总体而言，这些创新不仅增强了泡罩包装的功能性和可持续性，而且满足了製药业对以患者为中心的解决方案不断增长的需求。因此，上述因素正在促进药品泡罩包装市场的发展。

医疗废弃物成长率

医疗废弃物的增加预计将成为药品泡罩包装市场的重要限制因素。这是由于日益增加的环境问题和监管压力。吸塑包装虽然可以有效保护药物并延长保质期，但主要由塑胶和铝组成，这使得处理和回收工作变得复杂。

泡罩包装中所用材料的复杂性使得它们难以回收，从而产生大量废物，这些废物通常最终进入垃圾掩埋场或焚化炉。这不仅会导致环境退化，还会引起消费者和监管机构对药品包装实践可持续性的担忧。公司需要创新和调整其包装策略来解决这些问题，同时遵守旨在减少浪费和促进永续性的不断发展的法规。

The pharmaceutical blister packaging market includes the usage of pre-formed plastic packaging designed to securely hold individual doses of medications, such as tablets, capsules, and lozenges. This packaging solution is essential for enhancing the shelf life of pharmaceuticals by providing effective barrier protection against air, moisture, and contamination. Blister packs typically consist of a cavity formed from thermoformed plastic or aluminum, often sealed with a backing material such as paperboard or foil.

Market Dynamics: Drivers & Restraints

Innovations in packaging technology

Innovations in packaging technology are expected to significantly propel the pharma blister packaging market by enhancing safety, improving patient adherence, and promoting sustainability. Recent advancements have focused on integrating smart technologies, such as sensors and tracking devices, which can monitor medication usage and expiration dates.

Another significant innovation is the development of sustainable packaging solutions. Eco-friendly alternatives like Dry Molded Fiber (DMF) and paper-based blister packs are emerging as viable substitutes for traditional plastic packaging. These materials are both recyclable and biodegradable, addressing environmental concerns while still providing the necessary protective qualities for pharmaceutical products. For instance, in July 2024, Aluflexpack announced the development of a new product, the 4-Infinity Form. This blister pack, designed specifically for the pharmaceutical industry, is constructed entirely of lacquered aluminum, offering a sustainable and recyclable alternative to traditional multi-material packaging. The 4-Infinity Form solution addresses growing concerns about the environmental impact within the pharmaceutical packaging sector.

Advancements in design are also making blister packs more user-friendly, particularly for vulnerable populations such as the elderly. Features like child-resistant mechanisms and senior-friendly designs ensure that medications remain safe yet accessible. For instance, in November 2024, Schreiner MediPharm launched a New Child-Resistant Smart Blister Wallet. The product provides secure and smart packaging solutions for clinical trials. Schreiner MediPharm offers a wide variety of smart blister packs for clinical trials.

The introduction of customizable dosage tracking tools allows patients to easily monitor their medication schedules, thereby enhancing adherence and improving health outcomes. Overall, these innovations not only enhance the functionality and sustainability of blister packaging but also align with the growing demand for patient-centric solutions in the pharmaceutical industry. Thus, the above factors are contributing to the pharma blisters packaging market.

Growing rate of medical waste

The increasing rate of medical waste is expected to be a significant restraining factor for the pharma blister packaging market. This is due to increasing environmental concerns and regulatory pressures. Blister packaging, while effective in protecting medications and extending shelf life, is primarily composed of plastic and aluminum, which complicates disposal and recycling efforts.

The complexity of materials used in blister packs makes them challenging to recycle, resulting in a considerable amount of waste that often ends up in landfills or incinerators. This not only contributes to environmental degradation but also raises concerns among consumers and regulatory bodies regarding the sustainability of pharmaceutical packaging practices. Companies will need to innovate and adapt their packaging strategies to address these issues while complying with evolving regulations aimed at reducing waste and promoting sustainability.

Segment Analysis

The global Pharma Blisters Packaging market is segmented based on disease type, drug class, route of administration, distribution channel, end-user, and region.

Type:

Thermoformable blister packs segment is expected to dominate the global pharma blisters packaging market share

The thermoformable blister packs segment is expected to dominate the pharmaceutical blister packaging market due to several compelling factors that enhance its appeal to manufacturers and end-users alike. Thermoformable technology utilizes heat and pressure to shape plastic sheets into precisely formed cavities, allowing for intricate designs that accommodate various pharmaceutical products, including tablets and capsules, without compromising their integrity during storage and transport.

Companies are introducing various packaging solutions that are thermoformable. For instance, in November 2023, Coveris manufactured a new recyclable, flexible thermoforming film solution, called Formpeel P, for use in various medical packaging applications. The rising product innovations also contribute to the segment's growth.

One of the key advantages of thermoforming is its cost-effectiveness. Compared to cold-forming technology, thermoforming has lower initial tooling and equipment costs, making it more accessible for manufacturers looking to optimize production without incurring substantial expenses.

Geographical Analysis

North America is expected to hold a significant position in the global pharma blisters packaging market share

The North America is expected to hold a significant position in the global pharma blisters packaging market. This is due to the rising innovation in packaging solutions, increasing pharmaceutical production and consumption. The presence of a large number of packaging companies is expected to contribute to the region's market growth.

The presence of major pharmaceutical companies, including giants like Pfizer and Moderna, further solidifies North America's position in the blister packaging market. These companies not only dominate the production of high-demand pharmaceuticals but also invest heavily in research and development, leading to a continuous influx of new drug formulations that require effective packaging solutions.

The increasing focus on patient safety and adherence to medication regimens further emphasizes the need for effective packaging that can protect pharmaceuticals from environmental factors. Moreover, advancements in packaging technology are enhancing the functionality of blister packs, making them more user-friendly and sustainable. For instance, in October 2022, US-based pharmaceutical provider TekniPlex Healthcare introduced the world's first fully transparent recyclable mid-barrier blister package at Pack Expo in Chicago.

Asia Pacific is growing at the fastest pace in the global pharma blisters packaging market

Asia-Pacific is currently experiencing the fastest growth in the pharma blister packaging market. This growth is driven by the rising consumption of pharmaceutical products due to the incidence of several chronic diseases particularly in China and India, increasing pharmaceutical production by manufacturing companies, and the increasing innovations in packaging solutions.

Competitive Landscape

The major global players in the pharma blisters packaging market include ACG, KAA Timex LR, Amcor plc, Caprihans India Limited, Constantia Flexibles, Honeywell International Inc., Sonoco Products Company, The Dow Chemical Company, Tekni-Plex, Inc. and Korber AG among others.

Key Developments

In April 2022, Huhtamaki introduced a first-to-market sustainable innovation for the global pharmaceutical and healthcare industry. Huhtamaki's Push Tab(R) blister lid is mono-material PET and free from aluminum.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Pharma Blisters Packaging market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Material
3.3. Snippet by Application
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Innovations in packaging technology
- 4.1.2. Restraints
  - 4.1.2.1. Growing rate of medical waste
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Type

6.1. Introduction
- 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Thermoformable Blister Packs*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Face Seal Blister Packs
6.4. Full-face Seal Blister Packs
6.5. Clamshell Blister Packs
6.6. Cold-formable Blister Packs
6.7. Child-resistant Blister Packaging
6.8. Single-seal Blister Cards
6.9. Others

7. By Material

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 7.1.2. Market Attractiveness Index, By Material
7.2. PVC (Polyvinyl Chloride) *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. PVDC (Polyvinylidene Chloride)
7.4. Polychlorotrifluoroethylene
7.5. Aluminum-Aluminum (Alu-Alu)
7.6. Cold Form Foil (CFF)
7.7. Paper & Cardboard
7.8. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Tablets*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Capsules
8.4. Ampoules
8.5. Syringes
8.6. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. ACG*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. KAA Timex LR
11.3. Amcor plc
11.4. Caprihans India Limited
11.5. Constantia Flexibles
11.6. Honeywell International Inc.
11.7. Sonoco Products Company
11.8. The Dow Chemical Company
11.9. Tekni-Plex, Inc.

LIST NOT EXHAUSTIVE